CD74 and hepatocellular carcinoma: Therefore, the enriched ligand-receptor pair of CD74-MIF mainly mediated the crosstalk among immune cells and tumor cells in the TME of HCC, possibly through activating macrophages and other immune cells, including B cells, CD8+ T cells and NKT cells, in the TME.